Forecasting the global demand for HIV monitoring and diagnostic tests: A 2016-2021 analysis.

ABSTRACT:

Introduction

Despite considerable progress, just over half of the 37 million people eligible to start antiretroviral therapy (ART) have accessed treatment and millions of HIV-positive people still do not know their status. With demand for ART continuing to grow, meeting the ambitious 90-90-90 HIV treatment targets will depend on improved access to high-quality diagnostics to both diagnose infection and monitor treatment adherence in low and middle-income countries (LMICs). Robust projections of future demand for CD4, viral load (VL), HIV early-infant-diagnosis (EID) tests and HIV rapid diagnostic tests (RDTs) are needed as scale-up continues.

Methods

We estimate the current coverage for HIV diagnostics and project future demand to 2021 using a consolidated forecast using dat

SUBMITTER: Habiyambere V 

PROVIDER: S-EPMC6145505 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature